Table 1 Demographics and baseline biochemical parameters, qSOFA and SIRS scores in survivors and nonsurvivors [median (IQR) or (\( \overline{x}\pm \mathrm{SD} \))] of SFTS patients
Parameters | All patients | Survivors | nonsurvivors | P value |
|---|---|---|---|---|
N, (%) | 321(100) | 234 (72.9) | 87 (27.1) | < 0.001 |
Age (year), mean ± SD | 63.8 ± 11.2 | 61.3 ± 10.8 | 70.6 ± 9.2 | < 0.0001 |
Age < 60, n (%) | 111(34.6) | 97 (41.5) | 14 (16.1) | < 0.001 |
Age ≥ 60, n (%) | 210 (65.4) | 137 (58.6) | 73 (83.9) | < 0.0001 |
Male, n (%) | 170(53) | 116(49.6) | 54(62.1) | < 0.05 |
qSOFA score ≥ 2, n (%) | 44 (13.7) | 8 (3.4) | 36(41.4) | < 0.0001 |
SIRS score ≥ 2, n (%) | 124(38.6) | 66 (28.2) | 58(66.7) | < 0.0001 |
PCT ≥ 0.05, n (%) | 114/253(44.9) | 91/185(49.2) | 54/68(79.9) | < 0.0001 |
0.5 < PCT < 2, n (%) | 50 (19.8) | 8 (4.3) | 42 (61.8) | < 0.0001 |
PCT ≥ 2, n (%) | 19 (7.5) | 7(3.8) | 12 (17.7) | < 0.0001 |
Time in-hospital (days) (IQR) | 11(5–15) | 15(11–18) | 4(3–5) | < 0.0001 |
plasma lactate (mmol/L) (IQR) | 1.2(1–1.78) | 1.1(0.9–1.4) | 1.7(1.23–2.78) | < 0.0001 |
WBC (× 109/L) (IQR) | 3.15(1.9–5.0) | 3.1(1.9–4.3) | 3.5(1.8–6.6) | > 0.05 |
AST (U/L) (IQR) | 183(86.6–365.5) | 155(83–326.5) | 428.6(170.6–1019) | < 0.0001 |
sCr (μmol/L) (IQR) | 65.8(57.6–81.0) | 65.1(54.2–74.4) | 79.4(65.7–126.2) | < 0.0001 |
Hs-CRP (mmol/L) (IQR) | 3.8(1.44–11.4) | 1.8(1.26–5.7) | 0.36(0.11–1.02) | < 0.0001 |